Molecular Targets of Cannabidiol in Neurological Disorders.
Reading, United Kingdom. In Neurotherapeutics, Oct 2015
Of interest and after excluding unlikely and implausible targets, the remaining molecular targets of CBD with plausible evidence for involvement in therapeutic effects in neurological disorders (e.g., voltage-dependent anion channel 1, G protein-coupled receptor 55, CaV3.x, etc.) are associated with either the regulation of, or responses to changes in, intracellular calcium levels.